BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15242870)

  • 1. E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII).
    van der Stoep N; Quinten E; Marcondes Rezende M; van den Elsen PJ
    Blood; 2004 Nov; 104(9):2849-57. PubMed ID: 15242870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
    van der Stoep N; Quinten E; van den Elsen PJ
    J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells.
    Miura R; Kasakura K; Nakano N; Hara M; Maeda K; Okumura K; Ogawa H; Yashiro T; Nishiyama C
    PLoS One; 2016; 11(4):e0154094. PubMed ID: 27105023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.
    Holling TM; van der Stoep N; Quinten E; van den Elsen PJ
    J Immunol; 2002 Jan; 168(2):763-70. PubMed ID: 11777970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
    Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
    Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
    Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.
    Yoon H; Boss JM
    J Immunol; 2010 May; 184(9):5018-28. PubMed ID: 20363966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pT alpha promoter and enhancer are direct targets for transactivation by E box-binding proteins.
    Petersson K; Ivars F; Sigvardsson M
    Eur J Immunol; 2002 Mar; 32(3):911-20. PubMed ID: 11870636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility.
    Green MR; Yoon H; Boss JM
    J Immunol; 2006 Sep; 177(6):3865-73. PubMed ID: 16951349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
    Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
    Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
    Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
    J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
    O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
    J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
    Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
    J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IRF-2 DNA binding domain facilitates the activation of the class II transactivator (CIITA) type IV promoter by IRF-1.
    Xi H; Blanck G
    Mol Immunol; 2003 Jan; 39(11):677-84. PubMed ID: 12493643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1-mediated signaling induces MHC class II expression through activation of class II transactivator promoter III in mast cells.
    Nakano N; Nishiyama C; Yagita H; Koyanagi A; Ogawa H; Okumura K
    J Biol Chem; 2011 Apr; 286(14):12042-8. PubMed ID: 21321116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
    J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.